Range
- - -
Vol / Avg.
-/454.2K
Div / Yield
-
52 Wk
10.69 - 26.44
Mkt Cap
403M
Payout Ratio
-
Open
-
P/E
-
EPS
-0.41
Shares
31.4M
Outstanding
31.4M
Total Float
30.4M
Sector: Health Care.Industry: Biotechnology
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its lead drug candidate comprises CUE-101, a variant form of the cytokine Interleukin-2 and a T cell antigen to target and activate T cells specific to HPV-related cancers. The other products under pipeline are CUE-102, CUE-103, CUE-400, and CUE-401.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-09
REV
Q1 2021Est.ActualSurprise
EPS-0.380-0.410 -0.0300
REV1.553M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
CUECue Biopharma0%403M

Cue Biopharma Frequently Asked Questions

Q

How do I buy Cue Biopharma (CUE) stock?

A

You can purchase shares of Cue Biopharma (NASDAQ: CUE) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Cue Biopharma's (CUE) competitors?

Q

What is the target price for Cue Biopharma (CUE) stock?

A

The latest price target for Cue Biopharma (NASDAQ: CUE) was reported by Berenberg on November 24, 2020. The analyst firm set a price target for 30.00 expecting CUE to rise to within 12 months (a possible 133.83% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Cue Biopharma (CUE)?

A

The stock price for Cue Biopharma (NASDAQ: CUE) is $12.83 last updated Wed Jun 23 2021 20:00:04 GMT+0000 (Coordinated Universal Time).

Q

Does Cue Biopharma (CUE) pay a dividend?

A

There are no upcoming dividends for Cue Biopharma.

Q

When is Cue Biopharma (NASDAQ:CUE) reporting earnings?

A
Cue Biopharma’s Q2 earnings are confirmed for after-market on August 9, 2021.
Q

Is Cue Biopharma (CUE) going to split?

A

There is no upcoming split for Cue Biopharma.

Q

What sector and industry does Cue Biopharma (CUE) operate in?

A

Cue Biopharma is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.